Xcout Intel
Diamyd Medical B
Diamyd Medical develops precision medicine therapies focused on the prevention and treatment of type 1 diabetes. The company's primary product is retogatein (rhGAD65), an…
The full profile of Diamyd Medical B
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Diamyd Medical B →Already a subscriber? Sign in
Xcout Intel tracks Diamyd Medical B continuously — this profile deepens as new filings, funding, people and hiring data arrive.